Document Detail


Effect of lower-molecular weight heparin in the prevention of pancreatic encephalopathy in the patient with severe acute pancreatitis.
MedLine Citation:
PMID:  20104197     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To study the effect of lower-molecular weight heparin in the prevention of pancreatic encephalopathy (PE) in the patient with severe acute pancreatitis (SAP). METHODS: Two hundred sixty-five SAP patients were randomly divided into 2 groups: (1) conventional treatment group (C group, n = 130) and (2) conventional treatment plus lower-molecular weight heparin treatment group (LT group, n = 135). The clinical parameters, laboratory parameters and computed tomographic (CT) score of pancreatic necrosis (CTSPN), incidence of PE, and mortality in the 2 groups were compared. RESULTS: On admission, all the clinical parameters, laboratory parameters, and CTSPN in the 2 groups were not significantly different (P > 0.05). However, 1 to 2 weeks after treatment, the symptoms and signs improvement rate, the levels of blood and urine amylase, the CT score, and the Acute Physiology and Chronic Health Evaluation II score in the LT group were obviously lower than those in the C group (P < 0.05-0.01), and PE occurrence rate, mortality, and mean hospital stay in LT group were obviously lower than those in the C group (P < 0.05-0.01). CONCLUSIONS: Lower-molecular weight heparin can enhance the effect of conventional treatment of SAP and can markedly decrease the PE incidence and improve the survival rate of SAP. Lower-molecular weight heparin is a simple, safe, less expensive, and effective method for treatment of SAP. It can be used in every hospital.
Authors:
Xin-sheng Lu; Fu Qiu; Yi-xiong Li; Jie-qin Li; Qin-qiao Fan; Ri-guang Zhou
Related Documents :
24201397 - Sacrocolpopexy with rectopexy for pelvic floor prolapse improves bowel function and qua...
24874307 - Urinary diversion: long-term functional aspects.
24037567 - Long-term outcomes after endothoracic sympathetic block at the t4 ganglion for upper li...
24094657 - Urinary outcomes are significantly affected by nerve sparing quality during radical pro...
21927697 - Experience of 100 laparoscopic radical prostatectomies performed by a single surgeon: a...
17540817 - Heterogeneity in anatomic outcome of sacrospinous ligament fixation for prolapse: a sys...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Pancreas     Volume:  39     ISSN:  1536-4828     ISO Abbreviation:  Pancreas     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-04-26     Completed Date:  2010-08-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8608542     Medline TA:  Pancreas     Country:  United States    
Other Details:
Languages:  eng     Pagination:  516-9     Citation Subset:  IM    
Affiliation:
Department of General Surgery, Xiangya Hospital, Central South University, Changsha, China. xinshenglv@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Amylases / blood,  urine
Anticoagulants / therapeutic use
Brain Diseases / etiology,  prevention & control*
Child
Female
Fibrinogen / metabolism
Heparin, Low-Molecular-Weight / therapeutic use*
Humans
Length of Stay
Male
Middle Aged
Pancreatitis, Acute Necrotizing / complications*
Partial Thromboplastin Time
Prothrombin Time
Treatment Outcome
Young Adult
Chemical
Reg. No./Substance:
0/Anticoagulants; 0/Heparin, Low-Molecular-Weight; 9001-32-5/Fibrinogen; EC 3.2.1.-/Amylases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A New Neurogenic Vestibular Evoked Potential (N6) Recorded With the Use of Air-Conducted Sound.
Next Document:  Hospitalizations for Kawasaki Syndrome Among Children in the United States, 1997-2007.